DEA Approves Syndros® THC Oral Solution as the new pharmaceutical drug  has received approval for placement in Schedule II classification by the DEA.

DEA Approves Syndros® THC Oral Solution as the new pharmaceutical drug has received approval for placement in Schedule II classification by the DEA.

DEA Approves Syndros® THC Oral Solution as Schedule II

Cannabis Radio Live is a Livestream video podcast hosted by Daron Babin (Cannabis Radio Co-Founder) and Jorge Hermida (Host of Blunt Business). In this weekly show, Daron and Jorge hit the top headlines in the cannabis world as well as answer the questions and concerns from the Cannabis Community. Tune in every Tuesday at 3 pm Est/12 pm Pst on Cannabis Radio&#39;s Facebook, Youtube, and more!

News

News Commentary

Daily News

Cannabis Radio Live is a Livestream video podcast hosted by Daron Babin (Cannabis Radio Co-Founder) and Jorge Hermida (Host of Blunt Business). In this weekly show, Daron and Jorge hit the top headlines in the cannabis world as well as answer the questions and concerns from the Cannabis Community. Tune in every Tuesday at 3 pm Est/12 pm Pst on Cannabis Radio's Facebook, Youtube, and more!

Share DEA Approves Syndros® THC Oral Solution as Schedule II

Sign up to save your podcasts

DEA Approves Syndros® THC Oral Solution as Schedule II

DEA Approves Syndros® THC Oral Solution as Schedule II

More shows like Cannabis Radio Live

Good News with Nurse Heather

Grassroots Marketing

Blazin With Bobby Black

High On Healthy

The Tommy Chong Podcast

NCIA Cannabis Industry Voice

Cannabusiness Solutions

Blunt Business

420 Cloud Cannabis Connection